XML 38 R12.htm IDEA: XBRL DOCUMENT
v3.20.2

Mortgage Loans Payable and Unsecured Credit Facility | 9 Months Ended
--- | ---
Sep. 30, 2020
Debt Disclosure [Abstract] |
Mortgage Loans Payable and Unsecured Credit Facility | Note 5. Mortgage Loans Payable and Unsecured Credit Facility Debt and finance lease obligations are composed of the following at September 30, 2020:
|  |  |  | September 30, 2020 |
|  |  |  |  |  |  |  | Contractual |
|  | Maturity |  | Balance |  |  | interest rates |
Description |  | dates |  | outstanding |  |  | weighted-average |
Fixed-rate mortgage |  | Jun 2026 |  | $ | 45,907,000 |  |  | 3.9% |
Finance lease obligation |  | Sep 2050 |  |  | 5,640,000 |  |  | 5.3% |
Unsecured credit facilities (a): |  |  |  |  |  |  |  |  |  |
Variable-rate: |  |  |  |  |  |  |  |  |  |
Revolving credit facility |  | Sep 2021 (b) |  |  | 120,900,000 |  |  | 2.3% |
Term loan |  | Sep 2022 |  |  | 50,000,000 |  |  | 1.9% |
Fixed-rate (c): |  |  |  |  |  |  |  |  |  |
Term loan (d) |  | Feb 2021 |  |  | 75,000,000 |  |  | 3.9% |
Term loan |  | Feb 2022 |  |  | 50,000,000 |  |  | 3.3% |
Term loan |  | Sep 2022 |  |  | 50,000,000 |  |  | 3.5% |
Term loan |  | Apr 2023 |  |  | 100,000,000 |  |  | 3.5% |
Term loan |  | Sep 2024 |  |  | 75,000,000 |  |  | 3.9% |
Term loan |  | Jul 2025 |  |  | 75,000,000 |  |  | 4.8% |
|  |  |  |  | 647,447,000 |  |  | 3.4% |
Unamortized issuance costs |  |  |  |  | (2,194,000 | ) |  |  |  |
|  |  |  | $ | 645,253,000 |  |  |  |  |
| (a) | During the third quarter of 2020, the weighted average interest rate for the Company’s unsecured credit facilities increased 15 basis points (“bps”) as a result of an increase in the Company’s leverage ratio.
| (b) | The revolving credit facility is subject to a one-year extension at the Company’s option.
| (c) | The interest rates on these term loans consist of the London Interbank Offered Rate (“LIBOR”) plus a credit spread based on the Company’s leverage ratio, for which the Company has interest rate swap agreements which convert the LIBOR rates to fixed rates. Accordingly, these term loans are presented as fixed-rate debt.
| (d) | On October 27, 2020, the Company utilized its revolving credit facility to repay this term loan.
Unsecured Revolving Credit Facility and Term Loans On August 4, 2020, the Company amended its existing $300 million unsecured credit facility and term loans. After such amendments, the Company’s financial ratios and borrowing base are now all computed using the trailing four quarters as opposed to the current quarter annualized and interest rate swaps that are a hedge of existing debt are now excluded from the definition of debt. The $300 million unsecured credit facility consists of (1) a $250 million revolving credit facility, expiring on September 8, 2021, and (2) a $50 million term loan, expiring on September 8, 2022. The revolving credit facility may be extended, at the Company’s option, for an additional one-year period, subject to customary conditions. Under an accordion feature, the facility can be increased to $750 million, subject to customary conditions and lending commitments. Interest on borrowings under the revolving credit facility component can range from LIBOR plus 135 bps to 195 bps (165 bps at September 30, 2020 and as of this filing) and interest on borrowings under the term loan component can range from LIBOR plus 130 to 190 bps (160 bps at September 30, 2020 and as of filing), each based on the Company’s leverage ratio. Interest on borrowings under the unsecured credit facility and term loans are based on the Company’s leverage ratio. The Company’s unsecured credit facility and term loans contain financial covenants including, but not limited to, maximum debt leverage, maximum secured debt, minimum fixed charge coverage, and minimum net worth. In addition, the facility contains restrictions including, but not limited to, limits on indebtedness, certain investments and distributions. The Company’s failure to comply with the covenants or the occurrence of an event of default under the facilities could result in the acceleration of the related debt and exercise of other lender remedies. Although the credit facility is unsecured, borrowing availability is based on unencumbered property adjusted net operating income for the trailing twelve months, as defined in the agreements. As of the date of filing this Quarterly Report on Form 10-Q, the Company had $185.0 million outstanding and $44.1 available for additional borrowings under its revolving credit facility, and was in compliance with all financial covenants. Additionally, the COVID-19 pandemic may negatively impact the Company’s future ability to remain compliant with all financial covenants, including the ability to generate sufficient unencumbered property adjusted net operating income to support current borrowings. The Company’s unencumbered property adjusted net operating income was not significantly impacted by the COVID-19 pandemic until the quarter ended June 30, 2020. Accordingly, not until the quarter ended March 31, 2021, will the unencumbered property adjusted net operating income for the trailing twelve months fully reflect the negative impact of the COVID-19 pandemic. Derivative Financial Instruments The fair values of the interest rate swaps applicable to the unsecured term loans discussed above are included in other assets and deferred charges, net, and accounts payable and accrued liabilities on the consolidated balance sheet at September 30, 2020. Charges and/or credits relating to the changes in the fair value of the interest rate swaps are made to accumulated other comprehensive income (loss), limited partners’ interest, or operations (included in interest expense), as applicable. Over time, the unrealized gains and losses recorded in accumulated other comprehensive loss will be reclassified into earnings as an increase or reduction to interest expense in the same periods in which the hedged interest payments affect earnings. The Company estimates that approximately $7.2 million of accumulated other comprehensive loss will be reclassified as a decrease to earnings within the next twelve months. The following is a summary of the derivative financial instruments held by the Company at September 30, 2020 and December 31, 2019:
September 30, 2020
Designation/ |  |  |  |  |  |  |  | Fair |  |  | Maturity |  | Balance sheet
Cash flow |  | Derivative |  | Count |  |  | value |  |  | dates |  | location
Qualifying |  | Interest rate swaps |  |  | 7 |  |  | $ | 21,172,000 |  |  | 2021-2025 |  | Accounts payable and accrued liabilities
December 31, 2019
Designation/ |  |  |  |  |  |  |  | Fair |  |  | Maturity |  | Balance sheet
Cash flow |  | Derivative |  | Count |  |  | value |  |  | dates |  | location
Qualifying |  | Interest rate swaps |  |  | 2 |  |  | $ | 136,000 |  |  | 2020-2023 |  | Other assets and deferred charges, net
Qualifying |  | Interest rate swaps |  |  | 6 |  |  | $ | 7,180,000 |  |  | 2021-2025 |  | Accounts payable and accrued liabilities
The notional values of the interest rate swaps held by the Company at September 30, 2020 and December 31, 2019 were $425.0 million and $425.0 million, respectively. The following presents the effect of the Company’s derivative financial instruments on the consolidated statements of operations and the consolidated statements of equity for the three and nine months ended September 30, 2020 and 2019, respectively:
|  |  |  | (Loss) gain recognized in other |
|  |  |  | comprehensive (loss) income |
|  |  |  | (effective portion) |
Designation/ |  |  |  | Three months ended September 30, |  |  | Nine months ended September 30, |
Cash flow |  | Derivative |  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Qualifying |  | Interest rate swaps |  | $ | (552,000 | ) |  | $ | (2,883,000 | ) |  | $ | (18,141,000 | ) |  | $ | (15,837,000 | )
|  |  |  | Gain (loss) recognized in other |
|  |  |  | comprehensive (loss) income |
|  |  |  | reclassified into earnings (effective portion) |
|  |  |  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | Classification |  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
|  | Continuing Operations |  | $ | (2,032,000 | ) |  | $ | 216,000 |  |  | $ | (4,019,000 | ) |  | $ | 1,300,000 |
As of September 30, 2020 the Company believes it has no significant risk associated with non-performance of the financial institutions which are the counterparties to its derivative contracts.

X
- References No definition available. + Details
Name: | us-gaap_DebtDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -URI http://asc.fasb.org/topic&trid=2208564 + Details
Name: | us-gaap_DebtDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration